NCT03864029 - Retrospective Observational Safety Effectiveness With Kuvan in hpA | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 10, 2017

Primary Completion Date

March 9, 2018

Study Completion Date

July 25, 2018

Conditions

Tetrahydrobiopterin Deficiency

Interventions

DRUG

KUVAN

retrospective data on the effectiveness of past treatment with KUVAN®. It includes blood Phe level, physical development status, intelligence development status, etc., during treatment with KUVAN

Trial Locations (1)

610041

West China Hospital of Sichuan University, Chengdu